3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
50
Lymphoid
34
CNS
20
Genitourinary
12
Gastrointestinal
10
Other hematologic neoplasm
4
Gynecologic
4
Other
3
Thoracic
2
Head & Neck
2
Dermatologic
2
Sarcoma
1
Plasma cell
1
Myeloid
1
Classical hematology
1
Conditions
Sarcoma
956
Glioblastoma
299
Gliosarcoma
288
Osteosarcoma
285
Brain Neoplasms
195
Dendritic Cell Sarcoma, Interdigitating
188
Gastrointestinal Stromal Tumors
179
Bone Neoplasms
170
Lymphoma
160
Central Nervous System Neoplasms
160
Astrocytoma
155
Sarcoma, Ewing
149
Glioma
148
Precursor Cell Lymphoblastic Leukemia-Lymphoma
147
Lymphoma, Non-Hodgkin
143
Burkitt Lymphoma
139
Neoplasms
137
Recurrence
134
Lymphoma, Large B-Cell, Diffuse
128
Lymphoma, Follicular
128
Neuroblastoma
126
Rhabdomyosarcoma
125
Hodgkin Disease
124
Oligodendroglioma
123
Breast Neoplasms
122
Lymphoma, Mantle-Cell
117
Leukemia, Myeloid, Acute
117
Leukemia, Lymphocytic, Chronic, B-Cell
117
Lymphoma, B-Cell, Marginal Zone
113
Leukemia
111
Interventions
Surveys and Questionnaires
1
Interviews as Topic
1
Hematologic Tests
1
Echocardiography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cognitive Dysfunction
×
Sarcoma
×
Clear all
NCT04755140
2024-12-16
Endoprosthesis Metal Toxicity Study
Mayo Clinic
Completed
20 enrolled